Citadel Advisors
IDYA icon

Citadel Advisors’s IDEAYA Biosciences IDYA Stock Holding History

Citadel Advisors’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.6M Sell
679,400
-279,955
-29% -$9.39M ﹤0.01% 2185
2025
Q4 		$33.2M Sell
959,355
-357,636
-27% -$11.4M 0.01% 1812
2025
Q3 		$35.8M Sell
1,316,991
-508,912
-28% -$12.3M 0.01% 1698
2025
Q2 		$38.4M Buy
1,825,903
+320,823
+21% +$6.16M 0.01% 1458
2025
Q1 		$24.7M Sell
1,505,080
-331,750
-18% -$7.07M ﹤0.01% 1802
2024
Q4 		$47.2M Buy
1,836,830
+784,449
+75% +$22.2M 0.01% 1318
2024
Q3 		$33.3M Sell
1,052,381
-426,942
-29% -$16.2M 0.01% 1582
2024
Q2 		$51.9M Buy
1,479,323
+47,877
+3% +$1.9M 0.01% 1119
2024
Q1 		$62.8M Sell
1,431,446
-211,847
-13% -$9.11M 0.01% 1035
2023
Q4 		$58.5M Buy
1,643,293
+898,193
+121% +$26.8M 0.01% 1067
2023
Q3 		$20.1M Sell
745,100
-408,329
-35% -$10.4M ﹤0.01% 1848
2023
Q2 		$27.1M Buy
1,153,429
+142,313
+14% +$2.93M 0.01% 1586
2023
Q1 		$13.9M Buy
1,011,116
+124,257
+14% +$2.07M ﹤0.01% 2377
2022
Q4 		$16.1M Sell
886,859
-367,829
-29% -$6.19M ﹤0.01% 2197
2022
Q3 		$18.7M Buy
1,254,688
+533,644
+74% +$6.93M ﹤0.01% 1946
2022
Q2 		$9.95M Buy
721,044
+360,452
+100% +$4.01M ﹤0.01% 2696
2022
Q1 		$4.04M Buy
+360,592
New +$5.32M ﹤0.01% 4589
2021
Q1 		– Sell
-28,336
Closed -$397K – 13418
2020
Q4 		$397K Buy
+28,336
New +$384K ﹤0.01% 8583
2020
Q3 		– Sell
-248,005
Closed -$3.52M – 10355
2020
Q2 		$3.52M Buy
+248,005
New +$1.95M ﹤0.01% 3591

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Citadel Advisors's IDYA Position: Q1 2026 in Review

Citadel Advisors reduced its IDEAYA Biosciences (IDYA) stake by 29% in Q1 2026, selling an estimated $9.39M and leaving 679,400 shares worth $22.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2185.

Citadel Advisors first reported a position in IDYA in Q2 2020 and has held it in 19 quarters since. The position peaked at $62.8M in Q1 2024. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

  • Citadel Advisors held 679,400 shares of IDEAYA Biosciences worth $22.6M as of Q1 2026.
  • Citadel Advisors sold 279,955 IDEAYA Biosciences shares in Q1 2026, an estimated $9.39M.
  • IDEAYA Biosciences made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2185 holding.
  • Citadel Advisors first reported a position in IDEAYA Biosciences in Q2 2020 and has held it in 19 quarters since.
  • Citadel Advisors's IDEAYA Biosciences position peaked at $62.8M in Q1 2024.
  • 253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.